Pilot Project Program
试点项目计划
基本信息
- 批准号:9201296
- 负责人:
- 金额:$ 12.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alcoholic Liver DiseasesAwardCaliforniaCirrhosisCollaborationsCongressesDevelopmentDiseaseEducational workshopEnsureFacultyFosteringFoundationsFundingGenerationsGrantGrowthInvestigationManuscriptsMissionOutcomePancreatic DiseasesPathway interactionsPilot ProjectsPositioning AttributePostdoctoral FellowPreventiveProgress ReportsPublishingRecruitment ActivityResearchResearch PersonnelResearch SubjectsScienceScientistTherapeuticTraining ProgramsUnited States National Institutes of Healthimprovedinnovationinterestmembernext generationprogramssymposium
项目摘要
The center's Pilot Project Program represents the most critical mechanism to promote new and innovative investigational endeavors by young center scientists and established scientists from other fields. It fosters a transition of senior postdocs and early-stage investigators to the pathway to independence in their chosen research topics related to the center's theme. It facilitates generation of new leading-edge studies by established investigators from other fields on research subjects of our emphasis via collaboration with the center members and support from the center's cores. During the past 5 years, the Program has supported 12 investigators. Of these, 8 received the support for 2 or 3 years on the same projects. Ten funded investigators published or submitted total 21 manuscripts; 6 senior postdocs/junior scientists were promoted to faculty positions; 7 acquired NIH grants (4 R01, 1 K01, 1 R21, 1 R03 awards) and 4 foundation grants with 4 additional pending grants. We attribute this successful outcome to the program's interactive support via the cores, progress report meeting and annual symposium, single-topic workshops, educational programs and cross-utilization of complementary expertise. In the next funding cycle, the Program will continue to promote generation of new cutting-edge science in the field of ALPD and cirrhosis by pursuing the following five specific aims: 1) to explore and identify new and innovative research in pursuit of the center's research theme; 2) to identify and recruit new and qualified senior postdocs and young scientists into our field of interest and support their transition to academic independence; 3) to identify and recruit established investigators with expertise in other fields into research relevant to the center's theme; 4) support the growth of meritorious but unfunded studies into competitive projects that attract NIH support through R01 and other mechanisms; and 5) to integrate the center's other supportive mechanisms such as cores, educational and training programs, and training programs, and collaborative opportunities to maximize the potential of pilot projects for maturing to competitive studies.
该中心的试点项目计划是促进年轻中心科学家以及其他领域的科学家的最关键机制。它促进了高级博士后和早期研究人员的过渡到与中心主题相关的选择研究主题的独立之路。它通过与中心成员的合作以及中心的核心支持,促进了其他领域的知名研究对我们重点研究对象的研究人员的新领先研究的生成。在过去的5年中,该计划支持了12位调查人员。其中,有8个在同一项目上获得了2或3年的支持。十位资助的调查人员发表或提交了21项手稿; 6名高级博士后/初级科学家被提升为教师职位; 7项获得的NIH赠款(4 R01、1 K01、1 R21、1 R03奖项)和4项基金会补助金,并提供4个额外的待处理赠款。我们通过核心,进度报告会议和年度研讨会,单主题研讨会,教育计划以及互补专业知识的交叉利用来归因于该计划的互动支持。在下一个融资周期中,该计划将通过追求以下五个具体目标来促进ALPD和Cirrhosis领域的新尖端科学的产生:1)探索和识别新的,创新的研究以追求该中心的研究主题; 2)确定并招募新的和合格的高级博士后和年轻科学家进入我们感兴趣的领域,并支持他们向学术独立过渡; 3)确定并招募在其他领域具有专业知识的研究人员,以与该中心主题相关的研究; 4)支持对通过R01和其他机制吸引NIH支持的竞争项目的有功但无资金的研究; 5)为了整合中心的其他支持机制,例如核心,教育和培训计划以及培训计划,以及协作机会,以最大程度地提高试点项目的潜力,以使竞争性研究成熟。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIDEKAZU TSUKAMOTO其他文献
HIDEKAZU TSUKAMOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIDEKAZU TSUKAMOTO', 18)}}的其他基金
Southern California Research Center for ALPD and Cirrhosis
南加州 ALPD 和肝硬化研究中心
- 批准号:
9112542 - 财政年份:2015
- 资助金额:
$ 12.03万 - 项目类别:
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
9559537 - 财政年份:2013
- 资助金额:
$ 12.03万 - 项目类别:
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
9275383 - 财政年份:2013
- 资助金额:
$ 12.03万 - 项目类别:
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
10476009 - 财政年份:2013
- 资助金额:
$ 12.03万 - 项目类别:
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
乙醇诱导的肝脏发病过程中自噬的动态和机制
- 批准号:
9112813 - 财政年份:2013
- 资助金额:
$ 12.03万 - 项目类别:
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
乙醇诱导的肝脏发病过程中自噬的动态和机制
- 批准号:
8576712 - 财政年份:2013
- 资助金额:
$ 12.03万 - 项目类别:
相似国自然基金
生态补奖背景下草原牧户实现自主性减畜的机制、路径和政策研究
- 批准号:72374130
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
草原生态补奖政策对牧户兼业行为的影响机理研究——以内蒙古为例
- 批准号:72363025
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:72104063
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
草原生态补奖政策激励-约束下牧民生产行为决策机制及生态效应
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:
相似海外基金
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
抗纤维化和抗炎半合成氧甾醇 Oxy210 作为非酒精性脂肪性肝炎候选治疗药物的评价
- 批准号:
10697132 - 财政年份:2023
- 资助金额:
$ 12.03万 - 项目类别:
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
- 批准号:
10675684 - 财政年份:2022
- 资助金额:
$ 12.03万 - 项目类别:
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
- 批准号:
10525756 - 财政年份:2022
- 资助金额:
$ 12.03万 - 项目类别: